37-27-302 . Administration of prescription drugs -- when prohibited -- when allowed -- protocols -- rulemaking. (1) Except as provided in subsections (2) and (3), a licensed direct-entry midwife may not dispense or administer prescription drugs. (2) A licensed direct-entry midwife who has successfully completed accredited courses in pharmacology and intravenous therapy approved by the board and has obtained a license endorsement from the board may, during the practice of midwifery, directly obtain and administer the following: (a) oxygen; (b) postpartum antihemorrhagic agents, including: (i) pitocin (intramuscular); (ii) methylergonovine; (iii) misoprostol; (iv) tranexamic acid; and (v) other postpartum antihemorrhagic drugs allowed by board rule; (c) injectable local anesthetics for the repair of up to second-degree lacerations; (d) antibiotics for group b streptococcus prophylaxis consistent with guidelines of the United States centers for disease control and prevention; (e) epinephrine administered for anaphylactic shock; (f) intravenous fluids for fluid replacement and administration of approved medications; (g) rho(d) immune globulin to prevent maternal immune sensitization to certain fetal blood types; (h) newborn vitamin K or phytonadione (oral or intramuscular preparations); (i) in accordance with administrative rules adopted by the department of public health and human services, prophylactic eye agents to newborn infants; and (j) other medications as prescribed by a medical practitioner or naturopathic physician, including the use of devices as defined in 37-2-101 . (3) A licensed direct-entry midwife who has successfully completed accredited courses in pharmacology pursuant to subsection (2) may, during the practice of midwifery: (a) directly obtain terbutaline; and (b) administer terbutaline to a patient when given a direct order to do so from a licensed physician. (4) A licensed direct-entry midwife who administers drugs under this section must establish written protocol, including but not limited to: (a) procurement of prescription drugs, which must be procured from a wholesale drug distributor or pharmacy supplier licensed by the board of pharmacy provided for in 2-15-1733 ; (b) storage, inventory control, and disposal of prescription drugs; and (c) use and care of prescription drugs. (5) The board may adopt rules to implement this section.
‹ Prev All Montana sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.